| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2018-11-16 |
复牌提示：
2018-11-16 08:51:21 停牌，复牌日期 2018-11-19 00:00:01
|
| 2018-10-26 |
详情>>
股本变动：
变动后总股本3874.68万股
|
| 2018-10-26 |
详情>>
业绩披露：
2018年三季报(累计)每股收益1.70美元,归母净利润6590.00万美元,同比去年增长-49.27%
|
| 2018-09-27 |
股东大会：
将于2018-10-29召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal to adopt the Agreement and Plan of Merger, dated as of July 22, 2018 (as the same may be amended from time to time, the “Merger Agreement”), by and among LifePoint, RegionalCare Hospital Partners Holdings, Inc. (D/B/A RCCH HealthCare Partners), a Delaware corporation (“Parent”), and Legend Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Parent (“Merger Sub”), providing for the acquisition of LifePoint by Parent. Pursuant to the terms of the Merger Agreement, Merger Sub will merge with and into LifePoint, with LifePoint continuing as the surviving corporation and becoming a wholly-owned subsidiary of Parent (the “Merger”). A copy of the Merger Agreement is attached as Annex A to the proxy statement of which this notice forms a part.
2.To consider and vote on a proposal to approve one or more adjournments of the special meeting, if necessary or advisable, to solicit additional proxies if there are insufficient votes at the time of the special meeting to adopt the Merger Agreement.
3.To consider and cast an advisory (non-binding) vote on a proposal to approve certain “golden parachute” compensation that may be payable to LifePoint’s named executive officers in connection with the consummation of the Merger.
|
| 2018-09-13 |
详情>>
内部人交易：
Coggin Michael S.共交易2笔
|
| 2018-07-27 |
财报披露：
美东时间 2018-07-27 盘前发布财报
|
| 2018-07-27 |
详情>>
业绩披露：
2018年中报每股收益1.12美元,归母净利润4360.00万美元,同比去年增长-57.42%
|
| 2018-05-04 |
财报披露：
美东时间 2018-05-04 盘前发布财报
|
| 2018-05-04 |
详情>>
业绩披露：
2018年一季报每股收益-0.22美元,归母净利润-880万美元,同比去年增长-114.69%
|
| 2018-04-25 |
股东大会：
将于2018-06-05召开股东大会
会议内容 ▼▲
- 1.Elect two nominees as Class I directors of the Company;
2.Ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for 2018;
3.Approve, on a non-binding advisory basis, compensation of the Company's named executive officers;
4.Approve an amendment to the Company's Amended and Restated 2013 Long-Term Incentive Plan to (i) increase the number of authorized shares reserved for issuance; and (ii) clarify the minimum vesting periods for awards;
5.Transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2018-02-23 |
财报披露：
美东时间 2018-02-23 盘前发布财报
|
| 2018-02-23 |
详情>>
业绩披露：
2017年年报每股收益2.57美元,归母净利润1.02亿美元,同比去年增长-16%
|
| 2018-02-23 |
详情>>
业绩披露：
2015年年报每股收益4.14美元,归母净利润1.82亿美元,同比去年增长44.25%
|
| 2017-10-27 |
财报披露：
美东时间 2017-10-27 盘前发布财报
|
| 2017-10-27 |
详情>>
业绩披露：
2017年三季报(累计)每股收益3.24美元,归母净利润1.30亿美元,同比去年增长66.54%
|
| 2017-08-01 |
详情>>
业绩披露：
2017年中报每股收益2.55美元,归母净利润1.02亿美元,同比去年增长165.97%
|
| 2017-04-28 |
详情>>
业绩披露：
2017年一季报每股收益1.50美元,归母净利润5990.00万美元,同比去年增长177.31%
|
| 2017-04-25 |
股东大会：
将于2017-06-06召开股东大会
会议内容 ▼▲
- 1.Elect three nominees as Class III directors of the Company;
2.Ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for 2017;
3.Approve, on a non-binding advisory basis, compensation of the Company's named executive officers;
4.Approve, on a non-binding advisory basis, the frequency of the advisory vote on the compensation of the Company's named executive officers;
5.Approve the Company's 2013 Long-Term Incentive Plan as amended and restated to, among other things, (i) increase the number of authorized shares; (ii) prohibit the current payment of dividends on unvested awards; (iii) establish a minimum vesting period for awards; (iv) extend the term of the 2013 Plan; (v) update performance goals; and (vi) consolidate previously adopted amendments to the 2013 Long-Term Incentive Plan;
6.Transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2017-02-17 |
详情>>
业绩披露：
2016年年报每股收益2.90美元,归母净利润1.22亿美元,同比去年增长-32.99%
|
| 2016-10-28 |
详情>>
业绩披露：
2016年三季报(累计)每股收益1.83美元,归母净利润7800.00万美元,同比去年增长-39.49%
|
| 2016-04-26 |
股东大会：
将于2016-06-07召开股东大会
会议内容 ▼▲
- 1.Elect three nominees as Class II directors of the Company;
2.Approve, on a non-binding advisory basis, compensation of the Company's named executive officers;
3.Ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for 2016;
4.Transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2015-04-22 |
股东大会：
将于2015-06-02召开股东大会
会议内容 ▼▲
- 1. Elect three nominees as Class I directors of the Company;
2. Ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for 2015;
3. Approve, on a non-binding advisory basis, compensation of the Company's named executive officers;
4. Approve an amendment to the Company's 2013 Long-Term Incentive Plan;
5. Transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2014-04-23 |
股东大会：
将于2014-06-03召开股东大会
会议内容 ▼▲
- 1. Elect three nominees as Class III directors of the Company;
2. Ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for 2014;
3. Approve, on a non-binding advisory basis, compensation of the Company's named executive officers;
4. Approve the material terms of the performance goals under the Company's Executive Performance Incentive Plan;
5. Transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2013-04-24 |
股东大会：
将于2013-06-04召开股东大会
会议内容 ▼▲
- 1. Elect two nominees as Class II directors of the Company;
2. Ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for 2013;
3. Approve, on a non-binding advisory basis, compensation of the Company's named executive officers;
4. Approve the Company's 2013 Long-Term Incentive Plan;
5. Transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|